Omada Health OMDA 深 沪
已收盘 11-21 16:00:00 美东时间
18.60
+0.430
+2.37%
华盛通- 最 高18.945
- 今 开18.23
- 成交量 55.41万股
- 最 低 17.88
- 昨 收 18.17
- 总市值 10.71亿
- 52周最高 28.40
- 市盈率 静 --
- 换手率 0.96%
- 52周最低 14.14
- 委 比 -70.37%
- 总股本 5757.49万
- 历史最高 28.40
- 量 比 1.33
- 振 幅 5.86%
- 历史最低 14.14
- 每 手 1
- 风险率 2.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Omada Health to Participate in Evercore Healthcare Conference
Omada Health (Nasdaq: OMDA), a virtual between-visit healthcare provider, announced that senior management will participate in the 8th Annual Evercore Healthcare Conference in Miami, including a fireside chat on December 3, 2025, at 1:20 pm ET. The webcast will be available online at https://investors.omadahealth.com/news-events/events, with a replay following the event. Omada Health specializes in addressing cardiometabolic conditions and muscul...
11-20 14:05
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
BMO Capital Initiates Coverage On Omada Health with Outperform Rating, Announces Price Target of $27
BMO Capital analyst Sean Dodge initiates coverage on Omada Health (NASDAQ:OMDA) with a Outperform rating and announces Price Target of $27.
11-13 18:48
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Omada Health Reports Strong Growth and Innovation
Omada Health, Inc. (($OMDA)) has held its Q3 earnings call. Read on for the mai...
11-08 09:14
Omada Health Q3 EPS $(0.06) Beats $(0.13) Estimate, Sales $68.030M Beat $61.020M Estimate
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.13) by 54.89 percent. This is a 94.92 percent increase over losses of $(1.18) per share from the
11-07 05:19
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Omada Health To Present Data On Its Behavior Change Program On Participants Currently Or Previously On Glp-1 Medications For Weight Loss
Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada's behavior change program on members
11-05 01:02
Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer
Omada Health appoints Thomas Tsang, MD, MPH as Chief Medical Officer. Dr. Tsang brings extensive experience in clinical care, digital health, and policy. He previously led Valera Health to significant growth and has contributed to national healthcare frameworks. His appointment strengthens Omada’s position in virtual care innovation and chronic disease management. Omada continues to expand its GLP-1 Care Track and AI capabilities, including Omada...
10-27 13:00
